Christopher James | Vice President-Investor Relations |
Joe Ciaffoni | President & Chief Executive Officer |
Colleen Tupper | Chief Financial Officer |
Scott Dreyer | Chief Commercial Officer |
David Amsellem | Piper Sandler |
Serge Belanger | Needham & Company |
Glen Santangelo | Jefferies |
Oren Livnat | H.C. Wainwright |
Les Sulewski | Truist Securities |
Greetings. Welcome to the Collegium Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note that this conference call is being recorded.